Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons
2008 StandoutScience
Promoter Choice Determines Splice Site Selection in Protocadherin α and γ Pre-mRNA Splicing
2002 StandoutNobel
Structure of the PAPP-ABP5 complex reveals mechanism of substrate recognition
2022 StandoutNobel
Human conditions of insulin-like growth factor-I (IGF-I) deficiency
2012
The in vivo positional identity gene expression code is not preserved in neural stem cells grown in culture
2003
The mechanisms of Hedgehog signalling and its roles in development and disease
2013 Standout
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Effects of Torcetrapib in Patients at High Risk for Coronary Events
2007 Standout
Neuronal specification in the spinal cord: inductive signals and transcriptional codes
2000 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Nicotinic acid induces secretion of prostaglandin D2 in human macrophages: An in vitro model of the niacin flush
2006
Spinal-cord injury
2002 Standout
Lactate Inhibits Lipolysis in Fat Cells through Activation of an Orphan G-protein-coupled Receptor, GPR81
2008
Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis
2014 Standout
High-Density Lipoprotein as a Therapeutic Target
2007
ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors
2006
From charcot to lou gehrig: deciphering selective motor neuron death in als
2001
Consensus guidelines for the design and implementation of clinical trials in ALS
1999
The free-energy principle: a unified brain theory?
2010 Standout
Transcriptional profile of primary astrocytes expressing ALS‐linked mutant SOD1
2008
Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways
2009 StandoutNobel
Amyotrophic lateral sclerosis
2011 Standout
Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
2009
Age-related increases in PGD2 expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice
2011
Nicotinic acid: an old drug with a promising future
2007
Specification of neuronal fates in the ventral neural tube
2001
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
2009 Standout
Cholesterol efflux pathways and other potential mechanisms involved in the athero‐protective effect of high density lipoproteins
2008
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches
2002
The Human Forkhead Protein FREAC-2 Contains Two Functionally Redundant Activation Domains and Interacts with TBP and TFIIB
1998
Protein aggregation and neurodegenerative disease
2004 Standout
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Functional Integration of Embryonic Stem Cell-Derived NeuronsIn Vivo
2004
Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling
2011 StandoutNobel
Update on strategies to increase HDL quantity and function
2009
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
2016 Standout
Niacin in cardiovascular prevention: mechanisms, efficacy, and safety
2007
Nicotinic Acid Receptor Agonists Differentially Activate Downstream Effectors
2007
Teaching old receptors new tricks: biasing seven-transmembrane receptors
2010 StandoutNobel
Hedgehog signaling in animal development: paradigms and principles
2001 Standout
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
2020 Standout
The trinity of COVID-19: immunity, inflammation and intervention
2020 Standout
β-Arrestin1 mediates nicotinic acid–induced flushing, but not its antilipolytic effect, in mice
2009 StandoutNobel
Coordinate Roles for LIM Homeobox Genes in Directing the Dorsoventral Trajectory of Motor Axons in the Vertebrate Limb
2000
Basic and clinical research on amyotrophic lateral sclerosis and other motor neuron disorders in Italy: recent findings and achievements from a network of laboratories
2004
Stem Cells and Cancer
2004 Standout
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Nicotinic Acid-Induced Flushing Is Mediated by Activation of Epidermal Langerhans Cells
2006
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
G protein-coupled receptors for energy metabolites as new therapeutic targets
2012
Novel drug development for amyotrophic lateral sclerosis
2000
Safety Considerations with Niacin Therapy
2006
Induced Neuronal Cells: How to Make and Define a Neuron
2011 StandoutNobel
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
2007 StandoutNature
Amyotrophic Lateral Sclerosis
2001 Standout
HCV and the hepatic lipid pathway as a potential treatment target
2011
Scurfin (FOXP3) Acts as a Repressor of Transcription and Regulates T Cell Activation
2001 StandoutNobel
Neurotrophic factors and neuro-muscular disease: II. GDNF, other neurotrophic factors, and future directions
1999
VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection
2004
Mast cell and eosinophil surface receptors as targets for anti-allergic therapy
2016
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
2017 Standout
The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
2022 StandoutNobel
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Amyotrophic lateral sclerosis
2000
Clinical Trials in Motor Neuron Diseases
1999
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation
2022 StandoutNobel
ALSUntangled Update 1: Investigating a bug (Lyme Disease) and a drug (Iplex) on behalf of people with ALS
2009
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Nicotinic Acid: Pharmacological Effects and Mechanisms of Action
2007
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers
2021 StandoutNobel
A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone
2010 Standout
Hoxc10 and Hoxd10 regulate mouse columnar, divisional and motor pool identity of lumbar motoneurons
2007 StandoutNobel
Neuroscience: Breaking Down Scientific Barriers to the Study of Brain and Mind
2000 StandoutScienceNobel
Update on the Development of Antagonists of Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTH2). From Lead Optimization to Clinical Proof-of-Concept in Asthma and Allergic Rhinitis
2012
Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway
2006
Assessment of disease progression in motor neuron disease
2005
Plasma Insulin-like Growth Factors, Insulin-like Binding Protein-3, and Outcome in Metastatic Colorectal Cancer: Results from Intergroup Trial N9741
2008
Discrepancy between strong cephalic arterial dilatation and mild headache caused by prostaglandin D2(PGD2)
2010
Morphogen gradient interpretation
2001 StandoutNatureNobel
Works of Eseng Lai being referenced
A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults
2020
Effects of Laropiprant on Nicotinic Acid-Induced Flushing in Patients With Dyslipidemia††A list of study investigators appears in the Appendix.
2007
The effect of MK-0524, a prostaglandin D2 receptor antagonist, on prostaglandin D2-induced nasal airway obstruction in healthy volunteers
2007
Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis
2009
TWH Regulates the Development of Subsets of Spinal Cord Neurons
1997
Suppression of Niacin-induced Vasodilation with an Antagonist to Prostaglandin D2 Receptor Subtype 1
2007
Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humans
2008
Telencephalic progenitors maintain anteroposterior identities cell autonomously
1998
Antagonism of the prostaglandin D 2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans
2006
Effect of recombinant human insulin-like growth factor-I on progression of ALS
1997